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Plant lectins with blood group specificity for mammalian  red cells were first 
described more than 50 years ago (1). As part of this body of knowledge it is of 
special interest that  in  1908  Landsteiner and  Raubitschek  (2)  demonstrated 
the presence of a  panhemagglutinin in saline extracts of the red kidney bean, 
Phaseolus vulgaris.  In succeeding decades an increasing number of plant lectins 
were identified. However, it was only in  1960  that the lectin from Phaseolus 
vulgaris,  phytohemagglutinin  (PHA)  was  recognized as  being  distinctive by 
virtue of its possessing the additional properties of leukagglutination (3, 4) and 
mitogenic activities for human peripheral blood lymphocytes (5-10). For a time 
it appeared that among an extensive spectrum of plant lectins PHA might be 
unique in this regard. However, Fames et al.  (11) have recently reported that 
extracts of Phytolacca  americana,  pokeweed (PWM), although apparently lack- 
ing hemagglutinafing  and leukagglutinating  activity induced transformation 
of human lymphocytes in vitro. In this laboratory, further studies of the prop- 
erties of the pokeweed extracts disclosed that this material did in fact possess 
hemagglutinating and leukagglutinating activities; moreover, it was ascertained 
that the properties of pokeweed differed from PHA in a number of important 
respects. 
In this report we will present data on the biological and chemical properties 
of the pokeweed mitogen and in the subsequent papers,  consider the unique 
cytologic, biochemical, and fine structural features of the PWM-transformed 
cells (12,  13). 
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Materials and Methods 
Preparation of Pokeweed Mitogen  (PWM)  Fractions.--Roots  from  the  plant Phytolacca 
americana, pokeweed  growing in the vicinity of Bethesda,  were  harvested in early fall.  A 
TABLE I 
FractionaHon Scheme  for ,Pokeweed  Mitogen 
STEPS 
I  Saline Extraction 
H  Heat Coagulation 
IIIa  Ethanol Fraction- 
ation 
III b Trichloracefic 
Acid (TCA) 
Fractionafion 
Starting Material (5 lb. pokeweed  roots) 
Ground in Waring Blendor; extracted  overnight 
in  5  liters  0.01  ~  phosphate-buffered  saline, 
pH  7.3 at 4°C; filtered through cheesecloth. 
I  l 
Large particles  Filtrate 
(discarded)  I  centrifuged  15  rain 
/  27,000 g 4°C 
t  i 
Supernatant  Precipitate  (dis- 
carded) 
Floating material removed by 
suction 
100  ml  aliqu[ot  heated  to  [ 
75°C for 5 min in 500 ml  Saline Extract* 
Erlenmeyer flask;  floccu-  (frozen --20°C ) 
lent  precipitate  centri- 
fuged 11,700 g 15 rain 4°C 
I 
I 
Preciplta[e (heat-coagulated  Supernatant 
inert material discarded) 
a  b 
J  95%  eth  ol  added  drop-  Equal volume of 10% TCA 
wise at 0°C  to  final con-  Mded  to supernatant to 
centration of 60%; centri-  0°C,  centrifuged  27,000 
fuged 27,000 g, 15 min 4°C  g 15 rain 4°C 
r  I 
i  i  i  1 
Precipitate:~  Supernatant  Precipitate:~  Supernatant 
Ethanol fraction  (discarded)  TCA fracgon  (discarded) 
*  Stored at --20°C for at least 2 months without demonstrable loss in mitogenic activity. 
$ Dried first over absolute ethanol, then over anhydrous ether. 
diagrammatic representation of the procedure for preparing the various fractions is shown in 
Table I. 
Calcium Phosphate (Hydroxylapatite) Column Chromatography.--The method of Main et al. 
(14) was used in preparation of the calcium phosphate. Precipitated calcium phosphate was 
boiled with calcium hydroxide and then allowed  to sediment. To obtain an acceptable flow 
rate, only the crystals sedimenting during the first  10 min were used.  A column (47 X  255 BORfESON~  REISFELD~  CHESSIN~ WELSH~ AND  DOUGLAS  861 
mm) was packed with the calcium phosphate crystals in 0.005 ~¢ phosphate buffer at pH 7.5, 
and washed with this same buffer for 24 hr prior to the addition of the sample. 
The TCA fraction was dissolved in distilled water, centrifuged at 27,000 g, and the super- 
natant dialyzed for 24 hr against frequent changes of buffer. 300 ml of the dissolved TCA 
fraction (0.780 OD280 units/ml) was applied to the column. I0 ml fractions were collected at a 
flow rate of 70 ml/hr by stepwise elution with pH 7.5 phosphate buffer of the following molar- 
ities: 0.005 M (I000 ml), 0.05 ~  (1200 ml), and 0.5 M (I000 ml) and the relative protein concen- 
tration in each tube was estimated by measuring the absorption at 280 m/~. The eluted frac- 
tions were combined and dialyzed for 48 hr against frequent changes of distilled water and 
then lyophilized. 
Polyacrylamide Disc Electrophoresis.--Disc electrophoresis  on  polyacrylamide  gels  was 
performed according to the procedure described by Reisfeld et al. (15) using a modified buffer 
system (16)  without urea. Electrophoresis was carried out for 55 rain in a  7.5% acrylamide 
gel at a constant current of 2.5 ma/tube. Protein bands were localized by fixing the gel in 5% 
TCA or by staining with amido black. 
For the isolation and characterization of specific bands, duplicate gels,  electrophoresed in 
parallel, were fixed with TCA. The Rf value for each band was determined from the relative 
position of the buffer front marked with bromphenol blue to that of the TCA-precipitated 
protein bands. Having determined the Rf value for each band, duplicate gels, not fixed with 
TCA, were then cut into 1 mm sections, and the material from each section eluted in buffer 
and tested in hemagglutinatinn, leukagglutination, and mitogen assays. 
Pkytohemagglutinin (PHA).--The PHA used throughout this study was prepared accord- 
ing to the method of B6rjeson et al.  (17).  For use in hemagglutination, leukagglutination, 
and mitogen assays PHA was dissolved in 0.01 M phosphate-buffered saline at pH 7.3. 
Hemagglutination Assays.-- 
Test cells: Fresh human group AI, A2, B, and O  red cells collected in ACD,  were washed 
three times with 0.01 x, phosphate-buffered saline at pH 7.3 and resuspended in the same buf- 
fer. A final 2% red cell suspension was used in all hemagglutination assays. 
Saline titration: Serial twofold dilutions of 0.2 ml of phytomitogen were mixed with an equal 
volume of 4% red cell suspension, incubated for 2 hr at 37°C, and examined microscopically 
for agglutination. 
Dextran titration: A 4% red cell suspension was made up in Dextran (6% in saline, Abbott 
Laboratories, North Chicago, Illinois). Reaction mixtures were prepared and read as in saline 
agglutination titration. 
Titration with enzyme-treated cells: Trypsinized human red cells were prepared according 
to the method of Morton and Pickles (18), and ficin-treated red cells were prepared according 
to the method of Wiener and Katz (19).  The final reaction mixture containing 0.2 ml of en- 
zyme-treated red cells and 0.2 ml of phytomitogen  was incubated at 37°C for 2 hr and read 
microscopically. 
Mercaptoethanol Treatment of the Phflomitogens.--Equal  volumes of  phytomitogens and 
0.4 ~t mercaptoethanol in phosphate-buffered saline at pH  7.3 were incubated overnight at 
4°C. The reaction mixture was then dialyzed in the cold for 24 hr against frequent changes of 
0.01  M phosphate-buffered saline at pH  7.3. 
Periodate Treatment of the Phytomitogens.--Equal volumes  of  phytomitogen and  0.1 
sodium metaperiodate were incubated in the dark overnight at 4°C. The reaction mixture was 
then dialyzed  in the cold against frequent changes of 0.01  x~ phosphate-buffered saline at 
pH 7.3. 
Leukagglutination Assay.--Leukocyte suspensions for agglutination tests were prepared and 
examined according to the method of van Rood and van Leeuwen (20) with modifications as 
described by Chessin et al. (21). 
Antisera  to  Pokeweed Mitogen (PWM)  and  Phytohemagglutinin (PHA).--Antisera  to 862  HUM.AN PERIPHERAL  BLOOD LYMPHOCYTES IN  VITRO.  I 
PWM and PHA were prepared in rabbits. Adult New Zealand White  rabbits  each weighing 
3 to 5 kg were injected subcutaneously in six sites on the back with 1.0 ml of complete Freund's 
adjuvant  (85%  Bayol F,  15% Arlacel A  and  2.0 mg dried Mycobacterium butyricum H  37 
Rv) emulsified with saline containing 2.0 mg of either crude PWM saline extract or the ethanol 
fraction of PHA (17). The animals were given bimonthly booster injections of 1.0 ml of in- 
complete Freund's adjuvant emulsified with 2 mg of mitogen. 
Immunodiffusion and Immunodectrophoresis.--Double diffusion  studies  were  performed 
according to the method of Ouchterlony (22).  Microimmunoelectrophoresis was carried  out 
according to the technique of Grabar and Williams (23),  in an 0.1 ~t veronal buffer pH 8.4 at 
5 v/cm for a period of 45 min. Antibody diffusion was allowed to continue for 24 to 48 hr at 
room temperature.  Slides  were washed  free of unreacted  protein,  dried,  and  stained  with 
light green (24). 
Lymphocyte Cultures for Mitogen Assay. Cultures were prepared  from human  peripheral 
blood lymphocytes separated  on glass  wool columns.  Blood drawn from normal volunteers 
into Fenwal packs containing heparin was transferred to glass cylinders and the red cells were 
allowed to sediment by gravity at 37°C. The leukocyte-rich plasma was then passed through a 
glass wool column (100 ml syringe prepacked with 3 g of Pyrex glass wool filtering fiber 3950, 
Coming Glass Works, Coming, New York) and  the eluate centrifuged for 10 min at 250 g. 
The cell pellet was washed once with Dulbecco's phosphate-buffered saline and the lympho- 
cytes were counted and diluted in 85% E~gle's Spinner MEM (25) containing 0.02 mmole/ml 
fresh  L-glutamine penicillin  100  units/ml,  streptomycin  100 ~g/ml and  either  15%  heat- 
inactivated calf serum or 15% autologous serum. 
For all mitogen assays a  standard  inoculum of 3 )<  106 lymphocytes in 5 ml of growth 
medium was incubated at 37°C for 72 hr in 16 X  125 mm screw cap disposable glass tubes 
(Demuth Glass Works, Inc., Parkersburg, West Virginia). The morphological and biochemical 
characteristics of freshly harvested lymphocytes from glass wool columns will be described in 
greater detail in the following paper (12). 
Assay Methods.--Lymphocyte transformation was determined  by the following methods; 
radioactivity assay of thymidine-H  a incorporated into extracted  DNA, enumeration of the 
per cent labeled cells in  Giemsa-stained radioautographs  and  enumeration of the per cent 
transformed cells by phase and light microscopy. 
Radioactivity assays were performed on  lymphocyte cultures grown  continuously in the 
presence of 1  /zc thymidine-H3/ml  (TdR-H  8,  specific  activity,  1.9 c/mmole, Schwartz Bio- 
Research, Inc., Orangeburg, New York). Mter the appropriate incubation time, the cells were 
washed 3 times with 0.01 ~ phosphate-buffered saline at pH 7.3 centrifuged at 250 g, and then 
frozen at  -20°C. Mter freezing and thawing, the disrupted cells were digested with 100/~g 
papain in a 1 ml solution of 0.05 ~t phosphate buffer at pH 7.0 containing 5 m~t EDTA, 5 mM 
cysteine hydrochloride. The cell lysate was digested for 4 hr at 65 C in a Dubinoff water bath 
shaker. Mter digestion the suspension  was adjusted to approximately pH 8 with 1 ~ sodium 
hydroxide. DNA was precipitated by addition of 2 ml of 1% cetylttimethylammonium-bro- 
mide (CTAB). The tubes were then placed at room temperature overnight so that maximal 
DNA precipitation could take place (26).  The precipitate,  a water  insoluble CTAB-nucleic 
acid complex, was centrifuged at 2000 g for 45 rain,  dissolved in a  1:1 mixture of CTAB and 
1-propanol and added to Bray's solution (27), for counting in a liquid scintillation spectrome- 
ter (Packard 4000 Tri-Carb). 
RESULTS 
Properties of Different Pokeweed Fractions.-- 
Crude saline extract:  The crude  saline extract  of PWM  possesses  the ability 
to agglutinate human adult and cord A, B, and 0  red blood cells, to agglutinate 
white blood cells and  to  transform  human  peripheral  blood lymphocytes. BORJESON,  REISFELD,  CHESSIN,  WELSH,  AND  DOUGLAS  863 
The hemagglutinin  of PWM saline extract differs from PHA and most plant 
lectins (1) in that hemagglutination by PWM takes place optimally in the pres- 
ence of high  molecular  weight  substances;  e.g.,  6%  dextran,  PVP  (polyvinyl- 
pyrolidone) or heterologous serum rather than in saline. Hemagglutination will 
also take place with PWM after pretreatment of the red cells with either trypsin 
or ficin. The PWM hemagglutinin is inhibited by 0.003 •  EDTA, whereas simi- 
lar  concentrations  of  EDTA  do  not  inhibit  the  human  isoagglutinins.  The 
leukagglutinin of PWM similarly is weak in the presence of saline, strong in the 
TABLE II 
Properties of PWM Fractions 
Fraction 
~aline extract (step I) 
Jeat coagulated  saline extract  (step 
II) 
Ethanol precipitate (step III a) 
FCA precipitate (step III b) 
).05 ~ late moving fraction (hydroxyl- 
apatite column) 
).05  ~  front  moving  fraction  (hy- 
droxylapatite column) 
Agglutlnin 
~g N/ 
mg 
dry  I  End 
weight ,  point 
for 
sub-  hemag- 
stance*  g|utina- 
tion:~ 
99  2.5 
79  2.5 
--  3.1 
118  2.5 
69  150 
120  0.6 
Leukag- 
glutina- 
tion 
++ 
+++ 
+++ 
+++ 
-4- 
++ 
Mitogen 
Per cent  End point  TdR_HS 
for maximal  TdR -H3  incorporation§ 
incorporation:~  (transforma- 
tion index) 
n.d.Ii  22 
n.d.  29 
0.25  35 
0.25  60 
2.5  56 
<0.25  56 
* Kjeldahl determination. 
:~ Expressed as b~g dry weight of substance. 
§ Transformation index  =  counts per minute (PWM)/counts per minute (PHA). 
I1 Not determined. 
presence of dextran or serum, and is inhibited  by EDTA.  Both hemagglutina- 
tion and leukagglutination  by the crude saline extract can occur using as little 
as 2.5/~g of material. Heating the crude saline extract to 75°C precipitated  much 
of the inert protein with a  resultant albeit slight increase in mitogenic activity. 
The maximum transformation rate obtained with the crude saline extract (step 
I) was 22 %  while that of the heat-coagulated  saline extract (step II) was 29% 
(Table II). 
TCA  and  ethanol-precipitated fractions  of  the  heat-coagulated saline  extract: 
Precipitation  of  the  heat-coagulated  saline  extract  with  10%  trichloracetic 
acid  (TCA)  gave  almost  a  threefold  increase  in  the  transformation  index 
as  compared  to  the  saline  extract,  whereas  ethanol  fractionation  resulted  in 
only  a  small  increase  in  mitogenic  activity  (Table  II).  On  the  other  hand, 
hemagglutinating  activity  was  not  increased  by  step  II  (heat  coagulation), 864  HUMAN PERIPHERAL BLOOD LYMPHOCYTES IN  VITRO. I 
step III a  (ethanol fractionation) or step III b (TCA fractionation)  (Table II). 
Maximum transformation rate by both these fractions was achieved with 0.25 
#g of lyophilized substance. Absorption of the TCA fraction with either intact 
human red cells  or stroma resulted  in a  loss of the  hemagglutinating  activity 
without any appreciable loss in leukagglutinating or mitogenic activities,  while 
absorption with human leukocytes resulted in loss of all three activities. 
FIG. 1. Chromatographic  pattern of the PWM (TCA fraction)  eluted with 0.05 ~ phos- 
phate buffer at pH  7.5. Superimposed is the  electrophoretic  pattern  of the three  different 
eluates (0.05 M (F), 0.05 ~t (M), and 0.05 •  (L)) as seen after analytical  separation  on poly- 
acrylamide gels. The prominent  band (Rf 0.43) seen with  the front moving fraction  (F) is 
also seen to a lesser extent in middle (M), and late  (L) moving fractions. 
Fractions from column chromatography and polyacrylamide disc electrophoresis: 
Stepwise elution of the TCA-precipitated fraction from the calcium phosphate 
column  with  0.005,  0.05,  and  0.5  ~  phosphate  buffer  at  pH  7.5  resulted  in 
four peaks  (OD2s0).  The 0.05  M eluate  contained all  three  biological activities 
(Fig.  1)  with  more than  95 %  of all  hemagglutinating,  leukagglutinating,  and 
mitogenic activities present in the front moving fraction (F),  whereas the 0.05 
1~ late  moving fraction  (L)  contained less  than  5 %  of the biological activity. 
There was no activity present  in either  the 0.005  or 0.5 M eluates. 
Analytical separation of the various PWM fractions on polyacrylamide disc 
electrophoresis,  as  well  as  isolation  of  the  bands  and  reelectrophoresis  of gel 
slices  revealed  that  the mitogen,  hemagglutinin,  and  leukagglutinin  were inti- BORJESON,  REISFELD, CHESSIN, WELSH, AND  DOUGLAS  865 
mately associated  with  a  prominent  homogeneous band  with  an R]  value  of 
0.43  (Fig.  2).  All  three  activities  were  found to a  lesser  extent  in the middle 
fraction and least in the late fraction (Table II). This correlated well with the 
prominence  of the  active  band  in  the  different  fractions.  The  ultraviolet  ab- 
sorption spectrum of PWM (0.05 M front fraction) resembles that of PHA (Fig. 
3). Maximum absorption was seen at 280 m/z. A secondary peak present at 290 
m# suggested that this substance was rich in tryptophane. Biologically inactive 
protein fractions from both PHA and PWM did not contain the peak at 290 m#. 
FIG. 2. Analytical separation  of various PWM fractions  on polyacrylamide  disc  electro- 
phoresis. To each analytical  gel 100 #g (nitrogen equivalent)  of sample was applied. Electro- 
phoresis was carried out for 55 min in a 7% gel at a constant current  of 2.5 ma/tube. The gels 
were stained with amido black. 
A, ethanol fraction; B, TCA fraction; C, D, and E, the fractions eluted with 0.05 •  phos- 
phate buffer pH 7.5 from the calcium phosphate column. C, represents the front moving (F) 
fraction; D, the middle moving (M) fraction; and E, the late moving (L) fraction; F, isolation 
and reelectrophoresis of the major component shown in B. This component with an Rf value 
of 0.43 contained  all three biological activities  as seen in A to F. 
Double Diffusion and Immunoelectrophoresis Studies.--Double diffusion studies 
with rabbit anti-PHA against the crude pokeweed saline extract and PHA re- 
vealed a  single line  of partial  identity  (Fig.  4, L).  On the other hand,  rabbit 
antipokeweed serum did not give a  precipitation line against the purified PHA 
(Fig. 4, M). 
Immunoelectrophoresis performed with the crude saline extract of PWM and 
rabbit  antipokeweed  serum  gave  four lines  with  our saline  preparation  (Fig. 
4,  G)  and  eight  lines  with  another  preparation  (Grand  Island  Biologicals, 
Grand Island, New York) (Fig. 4, F). There were as many as three cathodal and 
five anodal lines seen with the latter preparation. 
During successive stages of purification,  immunoelectrophoretic  and double 
diffusion analysis with  the rabbit  anti-PWM  serum was performed with each 
fraction as shown in Fig. 4, A to K. It is shown that there is a loss of the cross- 866  HUMAN  PERIPHERAL  BLOOD  LYMPItOCYTES  IN"  VITRO.  I 
reactivity with PHA (as represented by the cathodal lines) at an early stage of 
purification (heat coagulation, step II) (Fig. 4, F to I). The most active mitogen, 
the 0.05 u  front moving fraction gave  a  single precipitation line on immuno- 
electrophoresis and immunodiffusion (Fig. 4, C to K). 
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Fla. 3.  Ultraviolet absorption spectra of PWM and PHA. 200/~g/ml of the purified PHA 
(17) and the 0.05  M front moving PWM fraction were dissolved in 0.01  ~  phosphate-buffered 
saline pH 7.3. The ultraviolet absorption spectra were determined in a Zeiss PMQ II spectro- 
photometer using a  I  cm silica cell. Curve A shows the spectrum for purified PWM  (0.05  M 
front moving fraction  (F)) with peaks at 280 and 290 m#.  Curve B  shows the spectrum for 
purified  PHA  with  peaks  at  the  same  wavelengths. 
DISCUSSION 
A  study  of  the  biological  and  chemical  properties  of  pokeweed  mitogen 
(PWM)  revealed  that  it  possessed  several  significant  features  which  distin- 
guished it from PHA.  These features are summarized in Table III. 
PWM  agglutinated  red  cells  optimally  in  the  presence  of  high  molecular 
weight substances or after pretreatment of red cells with proteolytic enzymes. It 
is of interest that the conditions optimal for PWM hemagglutination are simi- 
lar to those described for the human incomplete isoagglutinins or 7S antibodies, 
while the conditions for PHA hemagglutination are similar to those described 
for the  complete  isoagglutinins or  19S  antibodies  (28).  The  difference  in the 
hemagglutination pattern seen with these two mitogens may be related to the 
valency and the size of the molecules  as has been postulated for the human 
isoagglutinins (29). BORJESON, REISFELD, CHESSIN~ VCELSH,  AND DOUGLAS  867 
Fla.  4.  Immunoprecipitin studies.  A  to  I,  electrophoresis was  performed  in  2%  Noble 
Agar (Difco Laboratories, Inc., Detroit) in a 0.01  M veronal buffer, pH 8.4 at 5 v/cm for a 
period of 45 min. Antibody diffusion was allowed to continue for 48 hr. 
In A to G troughs contained anti-PWM. Antigen wells contained the following: A, 0.5 M 
PWM  fraction; B, 0.05  M PWM  late  (L)  fraction; C, 0.05  M PWM  front  (F)  fraction; D, 
PWM  heat-coagulated  fraction  (step  II);  E,  PWM  TCA fraction  (step  IIIb);  F,  PWM 
saline extract  (Grand  Island Biologicals); and  G, PWM  saline extract  (step  I). 
Troughs H  and  I  contained anti-PHA.  Antigen wells contained the following: H,  saline 
extract (step I); and I, purified PHA. 
K  to M, double diffusion  studies. K, center well, anti-PWM. Well 1, PWM saline extract 
(step I) ; Well 2, PWM TCA fraction (step IIIb) ; Well 3, PWM 0.05 ~ front (F) fraction; Well 
4, PWM 0.05 M late (L) fraction; Well 5, PWM 0.5 M fraction; and Well 6, PWM 0.05 ~ front 
(F) fraction. 
L, center well, PWM saline extract (step I). Well 7, Anti-PHA; and Well 8, Anti-PWM. 
M, center well, purified PHA. Well 9, Anti-PWM; Well 10, Anti-PHA. 868  HUMAN  PERIPHERAL  BLOOD  LYMPHOCYTES  IN  VITRO.  I 
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During fractionation of the pokeweed mitogen it was observed that both the 
hemagglutinating and leukagglutinating activities were intimately associated 
with the mitogenic activity. Absorption of either purified mitogen, with intact 
red cells or stroma resulted in loss of the hemagglutinating activity without any 
significant alteration in the leukagglutinating or mitogenic activity while ab- 
sorption with leukocytes resulted in loss of both the leukagglutinin and mitogen. 
These data indicated that the hemagglutinin and leukagglutinin were not only 
dissociable but that the receptor sites for these agglutinins might be  distinctly 
different. Further, the active moieties associated with the leukagglutinin and 
mitogen could not be separated by absorption. This latter finding has led some 
workers (3, 4) to conclude that leukagglutination is a necessary step in lympho- 
cyte transformation. In studies with staphylococcal filtrate (30, 31)  and anti- 
allotype sera (31), in which leukagglutination is not demonstrable, lymphocyte 
transformation occurs.  The fact that  the transformation of lymphocytes by 
PHA and PWM still occurs following coating of lymphocytes with the Vi anti- 
gen, a  suppressant of leukagglutination (32),  further supports the view that 
leukagglutination is not a necessary event in lymphocyte transformation. 
Although absorption of both mitogens with leukocytes removes both leukag- 
glutinating and mitogenic activities, the relationship between the leukagglutinin 
and mitogen is not yet defined. From the biological data it would seem likely 
that the macromolecular structure of PWM has at least two active moieties, 
one the hemagglutinin, and the other the leukagglutinin and mitogen. Further- 
more, these biological activities were not inactivated by treatment  with per- 
iodate or 2-mercaptoethanol, suggesting that neither the  splitting of carbon- 
carbon bonds in hexoses nor the reduction of possible  disulfide linkages alters 
any of the three biological activities under the stated conditions. 
The electrophoretic and chromatographic data indicate that the pokeweed 
mitogen has a different mobility and charge properties from PHA. This may be 
due to a difference in molecular weight, shape or size of the molecule, as sug- 
gested from both the  hemagglutinating properties  and  polyacrylamide disc 
electrophoresis. 
Analytical separation of the 0.05  •  front moving fraction (F)  eluted from 
calcium phosphate  column revealed that all  three  biological activities  were 
present in a single component which was homogeneous in polyacrylamide disc 
electrophoresis. This same band gave a  single line on immunoelectrophoresis. 
Although these data suggest homogeneity of the active fraction, it does not ex- 
clude the possibility that this fraction is made up of active subunits. Rigas et al. 
(33)  in  studying a  purified phytohemagglutinin has  reported  that  subunits 
derived  from  IRC  50  chromatography possess  both  hemagglutinating and 
mitogenic activities in different ratios, suggesting that these activities are pres- 
ent on the same molecule. 
Apart from the finding that the 0.05 ~  front fraction possessed all three bio- 870  HUMAN  PERIPHERAL  BLOOD LYM~HOCYTES  IN  VITRO.  I 
logical activities, mitogenic assays revealed that PWM gave a  transformation 
rate of 60 % of PHA. In the subsequent papers we will demonstrate  that the 
pokeweed mitogen is capable of stimulating a qualitatively distinct transforma- 
tion  with  the  expression  of biochemical,  histochemical,  and  fine  structural 
features resembling early antibody-forming ceils (12,  13). 
S~ARY 
The saline extract from the roots of Phytolacca  americana  (pokeweed) pos- 
sesses three biological properties; hemagglutinin, leukagglutinin, and mitogen. 
Fractionation and further purification on calcium phosphate column chroma- 
tography  revealed  that  the  biologically active  substance  was  eluted  in  the 
front moving fraction with 0.05 M phosphate buffer pH 7.5. Analytical separa- 
tion on polyacrylamide gels in disc electrophoresis yielded a single homogeneous 
band with an RI value of 0.43 containing all three biological activities.  This 
fraction had an ultraviolet absorption spectrum similar  to PHA, was stable to 
both periodate and mercaptoethanol treatment and gave a single band in double 
diffusion and immunoelectrophoretic analysis against the antibody prepared to 
the crude PWM saline extract. 
Absorption studies with red cells or stroma revealed that  the hemagglutinin 
could be selectively removed without significantly altering the mitogen, whereas 
absorption with leukocytes resulted in loss of both the mitogenic and leukag- 
glutinating activities. 
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